42 results on '"DE CATERINA, R"'
Search Results
2. Impaired adenylate cyclase signaling in acute myocardial ischemia: Impact on effectiveness of P2Y12 receptor antagonists
3. State of play and future direction with NOACs: An expert consensus
4. Effects of simulated hyperglycemia in vitro on insulin signaling in endothelial cells
5. Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors
6. 073_16968-G2 Non-Cardiac Syncope and All-Cause Mortality in Adults: A Meta-Analysis of Prospective Studies
7. Transplantation of adipose tissue mesenchymal cells overexpressing telomerase and myocardin promotes activation of the cardiomyogenic program and vasculogenesis, and preserves cardiac function in a murine model of myocardial infarction
8. Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment
9. Post receptor determinants of acute platelet response to clopidogrel in patients with symptomatic myocardial ischemia
10. Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry
11. Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry
12. Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Registry
13. D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial
14. Treatment Satisfaction in Patients with Atrial Fibrillation on New Oral Anticoagulants as Measured with Pact-Q2: Prefer in AF Registry
15. Clopidogrel “resistance”: Pre- vs post-receptor determinants
16. Health State in Patients with Atrial Fibrillation on New Oral Anticoagulants as Assessed with the New EQ-5D-5L Questionnaire: Prefer in AF Registry
17. Efficacy and Safety of Apixaban Compared With Warfarin According to Age for Stroke Prevention in Atrial Fibrillation
18. Commentary
19. Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD)
20. Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008
21. Abstract: P1140 THE OMEGA-3 FATTY ACID DOCOSAHEXAENOATE ATTENUATES INSULIN-INDUCED CD36 EXPRESSION IN HUMAN MISCOVASCULAR ENDOTHELIAL CELLS
22. Abstract: P646 TOWARDS AN UNDERSTANDING OF DIABETIC VASCULOPATHY: MECHANISMS OF HYPEROSMOLARITY-RELATED HYPERGLYCAEMIC DAMAGE
23. SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY
24. HIGH INSULIN IMPAIRS PI-3 KINASE/AKT-MEDIATED INSULIN SIGNALING IN HUMAN ENDOTHELIAL CELLS: AN IN VITRO INDUCTION OF INSULIN RESISTANCE?
25. THE OMEGA-3 FATTY ACID DOCOSAHEXAENOATE (DHA) REDUCES CYCLOOXYGENASE(COX)-2 INDUCTION BY INHIBITING NADP(H) OXIDASE AND PKC[epsiv]: POSSIBLE INVOLVEMENT OF 15-LIPOXIGENASE(LO)-1
26. THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR(PPAR)GAMMA AGONIST ROSIGLITAZONE (RSG) INHIBITS CYCLOOXYGENASE(COX)-2 EXPRESSION BY SUPPRESSING PKCAPLHA AND CREB ACTIVATION
27. HYDROXYTYROSOL, THE MAJOR OLIVE OIL PHENOLIC ANTIOXIDANT, REGULATES EXPRESSION AND ACTIVITY OF MATRIX METALLOPROTEINASE(MMP)-9 IN HUMAN MONOCYTOID CELLS - POSSIBLE CONTRIBUTION TO PLAQUE STABILITY
28. PROSTACYCLIN IMPROVES TRANSCORONARY MYOCARDIAL DELIVERY OF ADIPOSE TISSUE-DERIVED STROMAL CELLS
29. PO15-403 ENDOTHELIAL ACTIVITY IS RELATED TO DIET AND COMPONENTS OF THE METABOLIC SYNDROME, BUT NOT TO ADVANCED GLYCATION END-PRODUCTS IN HEALTHY SWEDISH MEN
30. Tu-S9:2 Omega-3 fatty acids and atherosclerosis: Evidence and mechanisms
31. Tu-P7:213 Relationships between autoantibodies against modified LDL and advanced glycation end-products in clinically healthy men
32. Tu-P7:290 Glycosylation in non-diabetic patients with atherosclerosis
33. T02-P-001 Rosuvastatin is cardioprotective,reducing ischemia/reperfusion injury in rat hearts through a modulation of nitric oxide synthase expression
34. Marine n−3 polyunsaturated fatty acids and coronary heart disease
35. Mechanisms for reduction of endothelial activation by oleate: inhibition of nuclear factor-κB through antioxidant effects
36. 3.P.192 Early degrees of LDL oxidation induce VCAM-1 expression in cultured endothelial cells
37. 3.P.193 Advanced glycation end-products induce global endothelial activation
38. Omega-3 fatty acids and endothelial leukocyte adhesion molecules
39. The 1st Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL): fatty acids and lipids from cell biology to human disease.
40. Inhibition of eicosanoid formation and lipocortin induction by glucocorticoids in human cell lines and in patients with inflammatory lung disease.
41. Induction of synthesis of lipocortin-I and inhibition of eicosanoid production in inflammatory cells: Evidence for a cell selectivity in glucocorticoid action
42. Association of the European Society of Cardiology echocardiographic probability grading for pulmonary hypertension with short and mid-term clinical outcomes after heart valve surgery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.